{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:38:06Z","timestamp":1793140686138,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20224Y0151"],"award-info":[{"award-number":["20224Y0151"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571423"],"award-info":[{"award-number":["82571423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030047"],"award-info":[{"award-number":["32030047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301339"],"award-info":[{"award-number":["82301339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300805"],"award-info":[{"award-number":["32300805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671273"],"award-info":[{"award-number":["81671273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271227"],"award-info":[{"award-number":["82271227"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","award":["2025-0313-YB-06"],"award-info":[{"award-number":["2025-0313-YB-06"]}],"id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","award":["RCQD2203"],"award-info":[{"award-number":["RCQD2203"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0110102"],"award-info":[{"award-number":["2019YFA0110102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1202804"],"award-info":[{"award-number":["2022YFF1202804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1202800"],"award-info":[{"award-number":["2022YFF1202800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116883","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:40:38Z","timestamp":1779306038000},"page":"116883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Role of ROCK-associated inflammation and redox imbalance in Parkinson's disease dyskinesia: evidence from animal and patient studies"],"prefix":"10.1016","volume":"183","author":[{"given":"Meihua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong-Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Cai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maowen","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Ran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116883_bb0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2026.116883_bb0110","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.116883_bb0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.116883_bb0140","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/mds.29344","article-title":"Long-duration response to levodopa, motor learning, and neuroplasticity in early Parkinson\u2019s disease","author":"Sciacca","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.abb8587","article-title":"Microglia modulate neurodegeneration in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"370","author":"Bartels","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.116883_bb0290","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.freeradbiomed.2011.01.032","article-title":"Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK","volume":"50","author":"Wang","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2026.116883_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105700","article-title":"Immune responses in the Parkinson\u2019s disease brain","volume":"168","author":"Weiss","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116883_bb0225","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00702-018-1874-4","article-title":"Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function","volume":"125","author":"Pisanu","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.intimp.2026.116883_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2014.10.017","article-title":"Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson\u2019s disease","volume":"73","author":"Bortolanza","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116883_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ejn.13482","article-title":"L-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?","volume":"45","author":"Carta","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2026.116883_bb0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s12640-021-00345-x","article-title":"Interferon-\u03b3 involvement in the Neuroinflammation associated with Parkinson\u2019s disease and L-DOPA-induced dyskinesia","volume":"39","author":"Ferrari","year":"2021","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116883_bib311","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jnc.15993","article-title":"The ratio of M1 to M2 microglia in the striatum determines the severity of L-Dopa-induced dyskinesias","volume":"167","author":"Rentsch","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2026.116883_bb0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/glia.22601","article-title":"Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis","volume":"62","author":"T\u00f6nges","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116883_bb0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2174\/1389450117666160401123825","article-title":"ROCK in CNS: different roles of isoforms and therapeutic target for neurodegenerative disorders","volume":"18","author":"Chong","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.intimp.2026.116883_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","article-title":"Inhibition of the microglial response is essential for the neuroprotective effects of rho-kinase inhibitors on MPTP-induced dopaminergic cell death","volume":"85","author":"Borrajo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2026.116883_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101367","article-title":"The RhoA-ROCK1\/ROCK2 pathway exacerbates inflammatory signaling in immortalized and primary microglia","volume":"12","author":"Glotfelty","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.116883_bb0280","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nbd.2012.04.010","article-title":"Involvement of microglial RhoA\/rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors","volume":"47","author":"Villar-Cheda","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116883_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2015.11.022","article-title":"Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: behavioral, molecular, and synaptic mechanisms","volume":"86","author":"Ghiglieri","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116883_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.01.013","article-title":"Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model","volume":"179","author":"Dekundy","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.intimp.2026.116883_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2026.116883_bb0175","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1111\/bph.15275","article-title":"Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"177","author":"Lopez-Lopez","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116883_bib312","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2014.10.026","article-title":"Parkinson\u2019s disease severity levels and MDS-Unified Parkinson\u2019s Disease Rating Scale","volume":"21","author":"Mart\u00ednez-Mart\u00edn","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0135","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.22341","article-title":"The unified dyskinesia rating scale: presentation and clinimetric profile","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbi.2016.11.014","article-title":"Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson\u2019s disease","volume":"61","author":"Breger","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.116883_bb0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12974-019-1603-4","article-title":"P2Y12 receptor mediates microglial activation via RhoA\/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine","volume":"16","author":"Jing","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116883_bb0180","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/antiox10091340","article-title":"NADPH-oxidase, rho-kinase and autophagy mediate the (pro)renin-induced pro-inflammatory microglial response and enhancement of dopaminergic neuron death","volume":"10","author":"Lopez-Lopez","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.intimp.2026.116883_bb0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-020-02023-9","article-title":"Substantia nigra Smad3 signaling deficiency: relevance to aging and Parkinson\u2019s disease and roles of microglia, proinflammatory factors, and MAPK","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116883_bb0055","first-page":"20140190","article-title":"Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson\u2019s disease induced by L-DOPA?","volume":"370","author":"Bortolanza","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.intimp.2026.116883_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brs.2021.11.016","article-title":"Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in Parkinson\u2019s disease","volume":"15","author":"Guerra","year":"2022","journal-title":"Brain Stimul."},{"key":"10.1016\/j.intimp.2026.116883_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116883_bb0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12640-016-9618-4","article-title":"Antidyskinetic effect of 7-Nitroindazole and sodium nitroprusside associated with amantadine in a rat model of Parkinson\u2019s disease","volume":"30","author":"Bortolanza","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.intimp.2026.116883_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuroscience.2008.07.016","article-title":"Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta","volume":"156","author":"Barnum","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116883_bb0005","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-\u03b3 levels in microglia and inhibits TNF-\u03b1 production: new evidences on neuroprotection in a progressive Parkinson\u2019s disease model","volume":"194","author":"Ar","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2026.116883_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nbd.2014.11.024","article-title":"Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats","volume":"74","author":"Martinez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2026.116883_bb0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.expneurol.2016.09.013","article-title":"Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson\u2019s disease","volume":"286","author":"Mulas","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.116883_bb0095","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1586\/ern.09.117","article-title":"Current strategies in the treatment of Parkinson\u2019s disease and a personalized approach to management","volume":"9","author":"Diaz","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.intimp.2026.116883_bb0300","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12974-020-01913-2","article-title":"Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders","volume":"17","author":"Yick","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116883_bb0210","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.intimp.2026.116883_bb0275","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","article-title":"Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability","volume":"96","author":"Vezzani","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2026.116883_bb0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuron.2020.11.007","article-title":"Shaping neuronal fate: functional heterogeneity of direct microglia-neuron interactions","volume":"109","author":"Cser\u00e9p","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.116883_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-020-2777-8","article-title":"Negative feedback control of neuronal activity by microglia","volume":"586","author":"Badimon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116883_bb0235","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.116883_bb0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41467-019-13781-3","article-title":"ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway","volume":"11","author":"Moskal","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.116883_bb0285","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.intimp.2026.116883_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/glia.22765","article-title":"Interaction between NADPH-oxidase and rho-kinase in angiotensin II-induced microglial activation","volume":"63","author":"Rodriguez-Perez","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.116883_bb0305","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1007\/s12035-025-04720-z","article-title":"The role of \u0394FosB in the pathogenesis of levodopa-induced dyskinesia: mechanisms and therapeutic strategies","volume":"62","author":"Zamanian","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.116883_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12264-016-0013-1","article-title":"Rho-associated kinase inhibitors promote microglial uptake via the ERK signaling pathway","volume":"32","author":"Fu","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.intimp.2026.116883_bb0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10143-024-02543-5","article-title":"Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia","volume":"47","author":"Luzzi","year":"2024","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.intimp.2026.116883_bb0100","doi-asserted-by":"crossref","DOI":"10.1042\/NS20220063","article-title":"Cytokine activity in Parkinson\u2019s disease","volume":"7","author":"Dzamko","year":"2023","journal-title":"Neuronal. Signal."},{"key":"10.1016\/j.intimp.2026.116883_bb0265","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.116883_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.intimp.2026.116883_bb0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2026.116883_bb0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12974-018-1339-6","article-title":"Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes","volume":"15","author":"Starhof","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.116883_bb0310","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-223277","article-title":"Blood and cerebrospinal fluid biomarkers of inflammation in parkinson\u2019s disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.intimp.2026.116883_bb0070","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","author":"Cenci","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2026.116883_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FBP.0000000000000441","article-title":"Classic animal models of Parkinson\u2019s disease: a historical perspective","volume":"30","author":"Hamadjida","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116883_bb0205","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson\u2019s disease in rodents: a new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.intimp.2026.116883_bb0250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2016.03.024","article-title":"Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats","volume":"280","author":"Sgroi","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.116883_bb0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fnbeh.2014.00331","article-title":"Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats","volume":"8","author":"Sgroi","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.intimp.2026.116883_bb0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrn.2017.91","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2026.116883_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2022","journal-title":"Nat. Rev. Neurosci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:50:07Z","timestamp":1783097407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":64,"alternative-id":["S1567576926007290"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116883","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of ROCK-associated inflammation and redox imbalance in Parkinson's disease dyskinesia: evidence from animal and patient studies","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116883"}}